Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1076
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome ; day:30 ; month:6 ; year:2016 ; pages:1-5
Zeitschrift für Kinderheilkunde ; (30.6.2016), 1-5
- Creator
-
Grenda, Ryszard
- Contributor
-
Jarmużek, Wioletta
Rubik, Jacek
Piątosa, Barbara
Prokurat, Sylwester
SpringerLink (Online service)
- DOI
-
10.1007/s00431-016-2747-1
- URN
-
urn:nbn:de:1111-2016070233824
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
13.10.4202, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grenda, Ryszard
- Jarmużek, Wioletta
- Rubik, Jacek
- Piątosa, Barbara
- Prokurat, Sylwester
- SpringerLink (Online service)
Other Objects (12)
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Post-transplant recurrence of steroid resistant nephrotic syndrome in children: the Italian experience
Post-transplant lymphoproliferative disorders
Post-transplant lymphoproliferative disease
Rituximab for nephrotic syndrome in children
Prevention of post-transplant lymphoproliferative disorder in pediatric kidney transplant recipients
Post-Transplant Maintenance Treatment Options in Multiple Myeloma
A marker chromosome in post-transplant bone marrow
Management of Post-transplant Hyperparathyroidism and Bone Disease
Post-Transplant Diabetes: Prevalence, Risk, and Management Challenges
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide
Deriving and understanding the risk of post-transplant recurrence of nephrotic syndrome in the light of current molecular and genetic advances